Inactive Instrument

Highlights Carmat Other OTC

Equities

Carmat: under pressure after equitization operation	06-14	CF
Carmat Raises EUR16 Million for Ongoing Operations, Clinical Trial	05-17	MT
Carmat: 16 million euros successfully raised	05-17	CF
Carmat: launches a fund-raising campaign of around €15 million	05-16	CF
Carmat "optimistic" about its artificial heart clinical trial, share price rises	05-06	RE
Carmat: progress in ongoing clinical study	05-06	CF
CARMAT Continues to Build on Its Momentum in the EFICAS Study	05-06	CI
Carmat SA Reiterates Sales Guidance for the Year 2024	05-06	CI
Carmat SA Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Carmat: final agreement with creditors	03-25	CF
Carmat Secures Two-year Extensions for Bank Loans	03-25	MT
Carmat: up sharply, broker upgrades to 'buy	02-01	CF
CARMAT : price target lowered by Oddo BHF	01-29	CF
Carmat: capital increase completed	01-29	CF
Carmat: launches a capital increase	01-17	CF
Carmat falls back, sales below expectations, capital increase to come	01-15	RE
Carmat: has passed the 50-implant milestone	01-15	CF
Artificial heart maker Carmat to launch capital increase soon	01-15	RE
Carmat Sa Provides Sales Guidance for the Year 2024	01-15	CI
Carmat: conditional agreement in principle with the EIB	01-12	CF

No results for this search